Estimating survival rates in MERS-CoV patients 14 and 45 days after experiencing symptoms and determining the differences in survival rates by demographic data, disease characteristics and regions: A worldwide study

Epidemiology and Infection

Volumn 146, Issue 4, 2018, Pages 489-495

  Ahmed, Anwar E ^a  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

Camels; MERS CoV; older age; Republic of Korea; Saudi Arabia

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; DISEASE TRANSMISSION; EARLY DIAGNOSIS; EDUCATION PROGRAM; FEMALE; GEOGRAPHY; HEALTH CARE ACCESS; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MORTALITY; RISK ASSESSMENT; RISK REDUCTION; SAUDI ARABIA; SEX RATIO; SOUTH KOREA; SURVIVAL RATE; SYMPTOM; ADOLESCENT; CHILD; CORONAVIRUS INFECTION; GLOBAL HEALTH; INFANT; ISOLATION AND PURIFICATION; PRESCHOOL CHILD; RISK FACTOR; VERY ELDERLY; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CORONAVIRUS INFECTIONS; DEMOGRAPHY; FEMALE; GLOBAL HEALTH; HUMANS; INFANT; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; RISK FACTORS; SURVIVAL RATE;

EID: 85042208308     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026881700293X     Document Type: Article

References (17)

1. Feikin DR (2015) Association of higher MERS-CoV virus load with severe disease and death, Saudi Arabia. Emerging Infectious Diseases 21, 2029-2035.
2. Al Ghamdi M, Alghamdi KM, Ghandoora Y, Alzahrani A, Salah F, Alsulami A, Bawayan MF, Vaidya D, Perl TM and Sood G (2016) Treatment outcomes for patients with Middle Eastern respiratory syndrome coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia. BMC Infectious Diseases 16, 174.
3. Ahmed AE (2017) The predictors of 3-and 30-day mortality in 660 MERS-CoV patients. BMC Infectious Diseases 17(1), 615.
4. Mohd HA, Memish ZA, Alfaraj SH, McClish D, Altuwaijri T, Alanazi MS, Aloqiel SA, Alenzi AM, Bafaqeeh F, Mohamed AM and Aldosari K (2016) Predictors of MERS-CoV infection: a large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia. Travel Medicine and Infectious Disease 14, 464-470.
5. Mizumoto K, Saitoh M, Chowell G, Miyamatsu Y and Nishiura H (2015) Estimating the risk of Middle East respiratory syndrome (MERS) death during the course of the outbreak in the Republic of Korea, 2015. International Journal of Infectious Diseases 31;39, 7-9.
6. Nam HS, Park JW, Ki M, Yeon MY, Kim J, Kim SW (2017) High fatality rates and associated factors in two hospital outbreaks of MERS in Daejeon, the Republic of Korea. International Journal of Infectious Diseases 16, 197-202. doi: 10. 1016/j. ijid. 2017. 02. 008.
7. Kim KH, Tandi TE, Choi JW, Moon JM and Kim MS (2017) Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications. Journal of Hospital Infection 28;95, 207-213.
8. Almekhlafi GA, Albarrak MM, Mandourah Y, Hassan S, Alwan A, Abudayah A, Altayyar S, Mustafa M, Aldaghestani T, Alghamedi A and Talag A (2016) Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients. Critical Care 20, 123.
9. Saad M, Omrani AS, Baig K, Bahloul A, Elzein F, Matin MA, Selim MA, Al Mutairi M, Al Nakhli D, Al Aidaroos AY and Al Sherbeeni N (2014) Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a singlecenter experience in Saudi Arabia. International Journal of Infectious Diseases 29, 301-306.
10. Mizumoto K, Endo A, Chowell G, Miyamatsu Y, Saitoh M and Nishiura H (2015) Real-time characterization of risks of death associated with the Middle East respiratory syndrome (MERS) in the Republic of Korea, 2015. BMC Medicine 30;13, 228.
11. Majumder MS, Kluberg SA, Mekaru SR and Brownstein JS (2015) Mortality risk factors for Middle East respiratory syndrome outbreak, South Korea, 2015. Emerging Infectious Diseases 21, 2088-2090.
12. Banik GR, Alqahtani AS, Booy R and Rashid H (2016) Risk factors for severity and mortality in patients with MERS-CoV: analysis of publicly available data from Saudi Arabia. Virologica Sinica 31, 81-84.
13. Rivers CM, Majumder MS and Lofgren ET (2016) Risks of death and severe disease in patients with Middle East respiratory syndrome coronavirus, 2012-2015. American Journal of Epidemiology 184, 460-464.
14. Chen X, Chughtai AA, Dyda A and MacIntyre CR (2017) Comparative epidemiology of Middle East respiratory syndrome coronavirus (MERSCoV) in Saudi Arabia and South Korea. Emerging Microbes & Infections 6(6), e51.
15. Ahmed AE (2017) Diagnostic delays in 537 symptomatic cases of MERSCoV infection in Saudi Arabia. International Journal of Infectious Diseases 62, 47-51.
16. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, Flemban H, Al-Nassir WN, Balkhy HH, Al-Hakeem RF (2013) Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. The Lancet Infectious Diseases 13: 752-761.
17. Pavli A, Tsiodras S and Maltezou HC (2014) Middle East respiratory syndrome coronavirus (MERS-CoV): prevention in travelers. Travel medicine and infectious disease 12, 602-608.